68 results
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals, Inc.
1 Aug 24
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
and third-party payor actions, including relating to reimbursement and pricing; risks related to regulatory compliance; and risks related
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals, Inc.
1 Jul 24
Regulation FD Disclosure
9:15am
litigation or disagreements with others; government and third-party payor actions, including relating to reimbursement and pricing; risks related
8-K
LBPH
Longboard Pharmaceuticals, Inc.
1 Jul 24
Regulation FD Disclosure
9:15am
with others; government and third-party payor actions, including relating to reimbursement and pricing; risks related to regulatory compliance; and risks
8-K
LBPH
Longboard Pharmaceuticals, Inc.
10 Jun 24
Regulation FD Disclosure
9:05am
; product liability or other litigation or disagreements with others; government and third-party payor actions, including relating to reimbursement
8-K
EX-99.1
hgxoiwtw xvpcd
10 Jun 24
Regulation FD Disclosure
9:05am
8-K
EX-99.1
sbbkor 9zo7
2 May 24
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
S-3ASR
norb 7u8gj
12 Mar 24
Automatic shelf registration
4:45pm
S-3ASR
EX-4.5
up2esrore6b
12 Mar 24
Automatic shelf registration
4:45pm
8-K
EX-99.1
fn87xhzh q3
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
424B5
4y5 w6m99htg735k18
4 Jan 24
Prospectus supplement for primary offering
4:48pm
424B5
akx7jk6glftm qnna
2 Jan 24
Prospectus supplement for primary offering
4:54pm
8-K
EX-99.1
ix8aq41
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
el92k4
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
EX-99.1
lnc 6cgu2
2 Nov 23
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:05pm